Cardiovascular Disease
2 competing products in clinical development for Cardiovascular Disease.
Pipeline by Phase
Phase 11
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Dulaglutide + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Evacetrapib | Eli Lilly | Phase 1 | Completed | 33 |